Lv61
2200 积分 2020-12-07 加入
Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review
2小时前
待确认
Advances and challenges in the treatment of osteosarcoma
2小时前
待确认
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
28天前
已完结
Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma
1个月前
已完结
Pushing the boundaries of liver resection for liver cancer
1个月前
已完结
Research advances in dual-conversion therapy for hepatocellular carcinoma
1个月前
已完结
Patterns of Response to Durvalumab Plus Tremelimumab and Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma
1个月前
已完结
Expanding the path to cure - a narrative review on optimizing multimodality sequencing in HCC
1个月前
已完结
Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancer
1个月前
已完结
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
1个月前
已完结
皖公网安备34019202002308
